cadenas

ITCC-054 BOSUTINIB/BCHILD

  • Innovative Therapies
    for Children with Cancer in Europe
  • Contact us

ITCC-054 BOSUTINIB/BCHILD

A phase I/II study of Bosutinib in pediatric patients with Chronic Myeloid Leukemia who are resistant or intolerant to at least one prior Tyrosine Kinase Inhibitor therapy

Promotor Name : Erasmus

Investigator Name : Zwaan Michel

Trial registered on clinicaltrial.gov: NCT04258943